prof: loretta nastoupil - pembrolizumab and rituximab in r/r fl
Published 7 years ago • 147 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:00
dr. nastoupil on pembrolizumab plus rituximab in relapsed follicular lymphoma
-
1:58
dr. nastoupil on efficacy with pembrolizumab and rituximab in follicular lymphoma
-
4:16
asst. prof. loretta nastoupil | ash 2017 | added value of checkpoint inhibitors in relapsed fl
-
2:30
dr nowakowski on the epcore nhl-1 trial results of epcoritamab in r/r follicular lymphoma
-
3:53
ash 2019 interview - dr loretta nastoupil - follicular lymphoma (part 1)
-
6:19
loretta nastoupil, md, discusses the transcend fl study
-
1:58
loretta nastoupil, md, on the importance of lymphoma awareness
-
23:44
novel immunotherapies (car t, bispecifics, and adcs) – loretta nastoupil, md
-
13:46
understanding follicular lymphoma with sarah rutherford, md
-
46:59
nuhs course immunohistochemistry in lymphoma diagnosis
-
4:23
chartese, non-hodgkin lymphoma survivor
-
1:29
dr. nastoupil on lymphoma highlights from the soho annual meeting
-
2:12
ash 2019 interview - dr loretta nastoupil - follicular lymphoma (part 2)
-
5:08
loretta nastoupil, md, discusses transform subgroup analyses
-
4:56
catherine diefenbach: polatuzumab vedotin for follicular lymphoma
-
16:23
dr loretta nastoupil: a case study on a male patient with follicular lymphoma and early progression
-
6:53
risk assessment for follicular lymphoma
-
1:26
dr. nastoupil on future treatment approaches in large cell lymphoma
-
1:16
controversies surrounding the management and treatment of lymphomas
-
6:15
therapy for relapsed follicular lymphoma
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
9:57
emerging therapies in relapsed follicular lymphoma: what’s next?